eBOOKS BY CATEGORY
Your Account
Neuroplasticity
New biochemical mechanisms
Price
Quantity
£29.99
(To see other currencies, click on price)
PDF
Add to basket  

MORE ABOUT THIS BOOK

Main description:

New research into neuroplasticity is a fascinating new research angle that could lead to improvements in therapy for the depressive disorders. In this volume, researchers in the field contribute chapters examining different aspects of this phenomenon.

Figures and tables help explain complicated concepts
This book provides a new angle on the treatment of depressive disorders


Contents:

Neuroplasticity — A New Approach to the Pathophysiology of Depression.- Glutamate-Mediated Neuroplasticity Deficits in Mood Disorders.- Regulation of Cellular Plasticity in Mood Disorders: The Role of the AMPA Receptor.- Cellular Plasticity and the Pathophysiology of Depression.- Clinical Consequences of the Role of Glutamate and Neuroplasticity in Depressive Disorder.


PRODUCT DETAILS

ISBN-13: 9781908517180
Publisher: Springer (Springer Healthcare Ltd.)
Publication date: January, 2012
Pages: 81

Subcategories: Neurology

MEET THE AUTHOR

Jean-Paul Macher is a psychiatrist and researcher in Clinical Neurosciences. Dr Macher’s main research areas are neuropsychopharmacology and functional brain imaging. He is a member of numerous societies in France, Europe and America, including the European College of NeuroPsychopharmacology (ECNP), Association of European Psychiatrists (AEP), Association Française de Psychiatrie Biologique (AFPB), Society for Mathematical Psychology (SMP), American Psychiatric Association (APA), Australasian Society of Biological Psychiatry (ASBP), European Sleep Research Society (ESRS), and the Chilean Association of Neurology, Psychiatry and Neurosurgery. Dr Macher is an expert on neuroscience, brain imaging and neuropsychopharmacology for the World Health Organization (WHO), President of the Research Methodology section of the World Psychiatric Association, and President of the International Foundation for Mental Health and Neurosciences. He is editor-in-chief of Dialogues in Clinical Neuroscience, and a member of the editorial boards of several journals. Dr Macher has written more than 200 scientific publications and many book chapters on neuropsychopharmacology.

Jean-Pierre Olié is Professor of Psychiatry at the Medical School of the University of Paris Descartes and Head of the Academic Department of Psychiatry at Sainte-Anne Hospital, Paris. He is a member of the Research Unit at INSERM on Pathophysiology of Mental Disorders. Dr Olié was secretary of Association Française de Psychiatrie Biologique (AFPB) and is Past President of this French society. He has been a member of several different International Committees: Paris (2004) and Munich (2008) CINP, Paris (2009) World Federation Societies of Biological Psychiatry. Dr Olié is also President of the Pierre Deniker Foundation, devoted to supporting research and teaching in psychiatry; President of the Scientific Committee of the annual French meeting in Psychiatry “Congrès de l’Encéphale”; and expert in psychiatry to the Paris courts. He is a corresponding member of the Academie Nationale de Medecine. Dr Olié is Editor-in-Chief of l’Encephale and member of the editorial board of several journals, and has written more than 400 publications in psychiatry and psychopharmacology, and also 15 books.

Jean-Pierre Olié is Professor of Psychiatry at the Medical School of the University of Paris Descartes and Head of the Academic Department of Psychiatry at Sainte-Anne Hospital, Paris. He is a member of the Research Unit at INSERM on Pathophysiology of Mental Disorders. Dr Olié was secretary of Association Française de Psychiatrie Biologique (AFPB) and is Past President of this French society. He has been a member of several different International Committees: Paris (2004) and Munich (2008) CINP, Paris (2009) World Federation Societies of Biological Psychiatry. Dr Olié is also President of the Pierre Deniker Foundation, devoted to supporting research and teaching in psychiatry; President of the Scientific Committee of the annual French meeting in Psychiatry “Congrès de l’Encéphale”; and expert in psychiatry to the Paris courts. He is a corresponding member of the Academie Nationale de Medecine. Dr Olié is Editor-in-Chief of l’Encephale and member of the editorial board of several journals, and has written more than 400 publications in psychiatry and psychopharmacology, and also 15 books.